The Effect of SAAE on Vascular Endothelial Function in PA Patients
NCT05561361 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-12-15
Summary
The study aims to assess the effect of superselective adrenal arterial embolization on vascular endothelial function in patients with primary aldosteronism based on brachial artery flow-mediated relaxation
Conditions
- Primary Aldosteronism
Interventions
- PROCEDURE
-
Super selective adrenal artery embolization
Superselective adrenal arterial embolization is an operation to inject embolic agent into adrenal artery through catheter to embolize part of adrenal gland, so as to reduce the secretion of adrenal hormone and reduce blood pressure.
- DRUG
-
Spironolactone
Aldosterone receptor antagonists are recommended by guidelines for the treatment of bilateral primary aldosteronism.
Sponsors & Collaborators
-
Second Affiliated Hospital of Nanchang University
lead OTHER
Principal Investigators
-
Yifei Dong · Second Affiliated Hospital of Nanchang University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2026-11-30
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism
NCT07328230 ·Status: RECRUITING ·Phase: NA
-
Adrenal Artery Ablation for Primary Aldosteronism
NCT03653845 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Adrenal Artery Ablation and Adrenalectomy in Patients With Primary Aldosteronism
NCT04269928 ·Status: COMPLETED
-
Diagnosing Variable Primary Aldosteronism.
NCT05765786 ·Status: RECRUITING
-
Adrenal Artery Ablation Treats Primary Aldosteronism
NCT03398785 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism
NCT07137364 ·Status: RECRUITING
-
The Comparison of Single Catheter and Double Catheter Adrenal Vein Sampling Methods Based on the Upper Limb Approach
NCT06737848 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Adrenal Artery Ablation for Uncontrolled Hypertension
NCT03660397 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism
NCT03174847 ·Status: COMPLETED
-
Sequential Combined Versus Single-Strategy Adrenal Venous Sampling for Primary Aldosteronism(SCOPE)
NCT07298954 ·Status: RECRUITING ·Phase: NA
-
Adrenal Artery Ablation for Primary Aldosteronism With Resistant Hypertension
NCT04345198 ·Status: COMPLETED ·Phase: NA
-
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
NCT05925569 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prospective Phenotyping of Autonomous Aldosterone Secretion
NCT03484130 ·Status: ACTIVE_NOT_RECRUITING
-
The Plasma Metabolomics Profiling of Primary Aldosteronism
NCT06500000 ·Status: COMPLETED
-
Statin Combined with Amlodipine Treats Primary Aldosteronism
NCT06523465 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Low Sodium Diet on Idiopathic Hyperaldosteronism
NCT05649631 ·Status: COMPLETED ·Phase: NA
-
Spatial Proteomics Profiles of Aldosterone-producing Adenoma and Unilateral Hyperplasia
NCT05927961 ·Status: UNKNOWN
-
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
NCT03020303 ·Status: COMPLETED ·Phase: PHASE3
-
Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
NCT04761354 ·Status: COMPLETED
-
Calcium Channel Blockade in Primary Aldosteronism
NCT04179019 ·Status: COMPLETED ·Phase: PHASE2
-
Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension
NCT00240656 ·Status: COMPLETED ·Phase: PHASE1
-
Study of CS-3150 in Patients With Primary Aldosteronism
NCT02885662 ·Status: COMPLETED ·Phase: NA
-
The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
NCT06236698 ·Status: COMPLETED
-
Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
NCT05030545 ·Status: RECRUITING ·Phase: PHASE4
-
Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat
NCT06569589 ·Status: RECRUITING